Loading…

Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study

Background Many studies on the quality of life (QoL) among the thyroid cancer survivors have shown conflicting results. This may be since many of these studies have not used thyroid cancer-specific questionnaires. Patients and methods In our study we have translated the EORTC THY-34, validated and s...

Full description

Saved in:
Bibliographic Details
Published in:European archives of oto-rhino-laryngology 2024-04, Vol.281 (4), p.1953-1960
Main Authors: Thiagarajan, Shivakumar, Fatehi, Khuzema, Menon, Nandini, Sawant, Mahesh, Pal, Ankita
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c298t-a8b7d2bb8b2c8125a9e671a4bd2e9f1755f27dc1863ebe6fbd71d93af37331363
container_end_page 1960
container_issue 4
container_start_page 1953
container_title European archives of oto-rhino-laryngology
container_volume 281
creator Thiagarajan, Shivakumar
Fatehi, Khuzema
Menon, Nandini
Sawant, Mahesh
Pal, Ankita
description Background Many studies on the quality of life (QoL) among the thyroid cancer survivors have shown conflicting results. This may be since many of these studies have not used thyroid cancer-specific questionnaires. Patients and methods In our study we have translated the EORTC THY-34, validated and served it in a cross-sectional study to the assess the QoL among thyroid cancer patients free of disease during their routine follow-up. Patients were categorized based on the duration from treatment completion, ATA risk stratification, treatment received, number of RAI sessions and thyroid function status during analysis. Results Overall, 220 thyroid cancer survivors were included in this study. In general, in the EORTC QLQ–C30, the global QoL of thyroid cancer patients were good with a mean score of 72.99. The highest score was that for social functioning (89.55). In the EORTC–THY34 all the patients in the cohort had relatively lower scores (on symptom scales). Overall, there was no difference in the QLQ–C30 and THY-34 QoL with respect to any of the categorization mentioned above. However, our thyroid cancer patients QoL scores were better and/or comparable to those in published literature and they were also better or comparable to the QoL of the general population those were available in literature. Conclusions There was no difference in the QoL scores based on various categories. To better understand the quality of life of these patients a prospective longitudinal study with baseline values and values at regular intervals might give us a better insight.
doi_str_mv 10.1007/s00405-024-08471-w
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2929131653</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2929131653</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-a8b7d2bb8b2c8125a9e671a4bd2e9f1755f27dc1863ebe6fbd71d93af37331363</originalsourceid><addsrcrecordid>eNp9kc1O3DAUha0KVAboC7BAXrIx-C9x0h0a0RYJCQnB2nKca2qUcaa-SdG8Aw9dzwx0ycrXOt89OrqHkDPBLwXn5go517xiXGrGG20Ee_1CFkIrzbSR9QFZ8FYZprUxR-QY8YVzXulWfSVHqlG8MbVYkLdrREBcQZroGOif2Q1x2mzHIQagMdHp9yaPsafeJQ-Zrt0UC4x0xpieiwr05v7hcfnBMVyDjyH64gU4xTElFzN8p46u87gVp_gXqC8zMtz-xuQGitPcb07JYXADwrf394Q8_bh5XP5id_c_b5fXd8zLtpmYazrTy65rOukbISvXQm2E010voQ3CVFWQpveiqRV0UIeuN6JvlQvKKCVUrU7Ixd63JNqltKuIHobBJRhntLKVrVCirlRB5R7dBc4Q7DrHlcsbK7jdtmD3LdjSgt21YF_L0vm7_9ytoP-_8nH2Aqg9gEVKz5Dtyzjncgf8zPYf8mmWtA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2929131653</pqid></control><display><type>article</type><title>Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study</title><source>Springer Link</source><creator>Thiagarajan, Shivakumar ; Fatehi, Khuzema ; Menon, Nandini ; Sawant, Mahesh ; Pal, Ankita</creator><creatorcontrib>Thiagarajan, Shivakumar ; Fatehi, Khuzema ; Menon, Nandini ; Sawant, Mahesh ; Pal, Ankita</creatorcontrib><description>Background Many studies on the quality of life (QoL) among the thyroid cancer survivors have shown conflicting results. This may be since many of these studies have not used thyroid cancer-specific questionnaires. Patients and methods In our study we have translated the EORTC THY-34, validated and served it in a cross-sectional study to the assess the QoL among thyroid cancer patients free of disease during their routine follow-up. Patients were categorized based on the duration from treatment completion, ATA risk stratification, treatment received, number of RAI sessions and thyroid function status during analysis. Results Overall, 220 thyroid cancer survivors were included in this study. In general, in the EORTC QLQ–C30, the global QoL of thyroid cancer patients were good with a mean score of 72.99. The highest score was that for social functioning (89.55). In the EORTC–THY34 all the patients in the cohort had relatively lower scores (on symptom scales). Overall, there was no difference in the QLQ–C30 and THY-34 QoL with respect to any of the categorization mentioned above. However, our thyroid cancer patients QoL scores were better and/or comparable to those in published literature and they were also better or comparable to the QoL of the general population those were available in literature. Conclusions There was no difference in the QoL scores based on various categories. To better understand the quality of life of these patients a prospective longitudinal study with baseline values and values at regular intervals might give us a better insight.</description><identifier>ISSN: 0937-4477</identifier><identifier>EISSN: 1434-4726</identifier><identifier>DOI: 10.1007/s00405-024-08471-w</identifier><identifier>PMID: 38308761</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Head and Neck ; Head and Neck Surgery ; Medicine ; Medicine &amp; Public Health ; Neurosurgery ; Otorhinolaryngology</subject><ispartof>European archives of oto-rhino-laryngology, 2024-04, Vol.281 (4), p.1953-1960</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-a8b7d2bb8b2c8125a9e671a4bd2e9f1755f27dc1863ebe6fbd71d93af37331363</cites><orcidid>0000-0003-1957-3338</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38308761$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thiagarajan, Shivakumar</creatorcontrib><creatorcontrib>Fatehi, Khuzema</creatorcontrib><creatorcontrib>Menon, Nandini</creatorcontrib><creatorcontrib>Sawant, Mahesh</creatorcontrib><creatorcontrib>Pal, Ankita</creatorcontrib><title>Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study</title><title>European archives of oto-rhino-laryngology</title><addtitle>Eur Arch Otorhinolaryngol</addtitle><addtitle>Eur Arch Otorhinolaryngol</addtitle><description>Background Many studies on the quality of life (QoL) among the thyroid cancer survivors have shown conflicting results. This may be since many of these studies have not used thyroid cancer-specific questionnaires. Patients and methods In our study we have translated the EORTC THY-34, validated and served it in a cross-sectional study to the assess the QoL among thyroid cancer patients free of disease during their routine follow-up. Patients were categorized based on the duration from treatment completion, ATA risk stratification, treatment received, number of RAI sessions and thyroid function status during analysis. Results Overall, 220 thyroid cancer survivors were included in this study. In general, in the EORTC QLQ–C30, the global QoL of thyroid cancer patients were good with a mean score of 72.99. The highest score was that for social functioning (89.55). In the EORTC–THY34 all the patients in the cohort had relatively lower scores (on symptom scales). Overall, there was no difference in the QLQ–C30 and THY-34 QoL with respect to any of the categorization mentioned above. However, our thyroid cancer patients QoL scores were better and/or comparable to those in published literature and they were also better or comparable to the QoL of the general population those were available in literature. Conclusions There was no difference in the QoL scores based on various categories. To better understand the quality of life of these patients a prospective longitudinal study with baseline values and values at regular intervals might give us a better insight.</description><subject>Head and Neck</subject><subject>Head and Neck Surgery</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurosurgery</subject><subject>Otorhinolaryngology</subject><issn>0937-4477</issn><issn>1434-4726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kc1O3DAUha0KVAboC7BAXrIx-C9x0h0a0RYJCQnB2nKca2qUcaa-SdG8Aw9dzwx0ycrXOt89OrqHkDPBLwXn5go517xiXGrGG20Ee_1CFkIrzbSR9QFZ8FYZprUxR-QY8YVzXulWfSVHqlG8MbVYkLdrREBcQZroGOif2Q1x2mzHIQagMdHp9yaPsafeJQ-Zrt0UC4x0xpieiwr05v7hcfnBMVyDjyH64gU4xTElFzN8p46u87gVp_gXqC8zMtz-xuQGitPcb07JYXADwrf394Q8_bh5XP5id_c_b5fXd8zLtpmYazrTy65rOukbISvXQm2E010voQ3CVFWQpveiqRV0UIeuN6JvlQvKKCVUrU7Ixd63JNqltKuIHobBJRhntLKVrVCirlRB5R7dBc4Q7DrHlcsbK7jdtmD3LdjSgt21YF_L0vm7_9ytoP-_8nH2Aqg9gEVKz5Dtyzjncgf8zPYf8mmWtA</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Thiagarajan, Shivakumar</creator><creator>Fatehi, Khuzema</creator><creator>Menon, Nandini</creator><creator>Sawant, Mahesh</creator><creator>Pal, Ankita</creator><general>Springer Berlin Heidelberg</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1957-3338</orcidid></search><sort><creationdate>20240401</creationdate><title>Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study</title><author>Thiagarajan, Shivakumar ; Fatehi, Khuzema ; Menon, Nandini ; Sawant, Mahesh ; Pal, Ankita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-a8b7d2bb8b2c8125a9e671a4bd2e9f1755f27dc1863ebe6fbd71d93af37331363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Head and Neck</topic><topic>Head and Neck Surgery</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurosurgery</topic><topic>Otorhinolaryngology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thiagarajan, Shivakumar</creatorcontrib><creatorcontrib>Fatehi, Khuzema</creatorcontrib><creatorcontrib>Menon, Nandini</creatorcontrib><creatorcontrib>Sawant, Mahesh</creatorcontrib><creatorcontrib>Pal, Ankita</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European archives of oto-rhino-laryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thiagarajan, Shivakumar</au><au>Fatehi, Khuzema</au><au>Menon, Nandini</au><au>Sawant, Mahesh</au><au>Pal, Ankita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study</atitle><jtitle>European archives of oto-rhino-laryngology</jtitle><stitle>Eur Arch Otorhinolaryngol</stitle><addtitle>Eur Arch Otorhinolaryngol</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>281</volume><issue>4</issue><spage>1953</spage><epage>1960</epage><pages>1953-1960</pages><issn>0937-4477</issn><eissn>1434-4726</eissn><abstract>Background Many studies on the quality of life (QoL) among the thyroid cancer survivors have shown conflicting results. This may be since many of these studies have not used thyroid cancer-specific questionnaires. Patients and methods In our study we have translated the EORTC THY-34, validated and served it in a cross-sectional study to the assess the QoL among thyroid cancer patients free of disease during their routine follow-up. Patients were categorized based on the duration from treatment completion, ATA risk stratification, treatment received, number of RAI sessions and thyroid function status during analysis. Results Overall, 220 thyroid cancer survivors were included in this study. In general, in the EORTC QLQ–C30, the global QoL of thyroid cancer patients were good with a mean score of 72.99. The highest score was that for social functioning (89.55). In the EORTC–THY34 all the patients in the cohort had relatively lower scores (on symptom scales). Overall, there was no difference in the QLQ–C30 and THY-34 QoL with respect to any of the categorization mentioned above. However, our thyroid cancer patients QoL scores were better and/or comparable to those in published literature and they were also better or comparable to the QoL of the general population those were available in literature. Conclusions There was no difference in the QoL scores based on various categories. To better understand the quality of life of these patients a prospective longitudinal study with baseline values and values at regular intervals might give us a better insight.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>38308761</pmid><doi>10.1007/s00405-024-08471-w</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-1957-3338</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0937-4477
ispartof European archives of oto-rhino-laryngology, 2024-04, Vol.281 (4), p.1953-1960
issn 0937-4477
1434-4726
language eng
recordid cdi_proquest_miscellaneous_2929131653
source Springer Link
subjects Head and Neck
Head and Neck Surgery
Medicine
Medicine & Public Health
Neurosurgery
Otorhinolaryngology
title Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T20%3A50%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20quality%20of%20life%20in%20thyroid%20cancer%20patients%20using%20the%20EORTC%20thyroid-specific%20questionnaire:%20a%20prospective%20cross-sectional%20study&rft.jtitle=European%20archives%20of%20oto-rhino-laryngology&rft.au=Thiagarajan,%20Shivakumar&rft.date=2024-04-01&rft.volume=281&rft.issue=4&rft.spage=1953&rft.epage=1960&rft.pages=1953-1960&rft.issn=0937-4477&rft.eissn=1434-4726&rft_id=info:doi/10.1007/s00405-024-08471-w&rft_dat=%3Cproquest_cross%3E2929131653%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c298t-a8b7d2bb8b2c8125a9e671a4bd2e9f1755f27dc1863ebe6fbd71d93af37331363%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2929131653&rft_id=info:pmid/38308761&rfr_iscdi=true